Form 8-K - Current report:
SEC Accession No. 0001193125-16-483467
Filing Date
2016-02-29
Accepted
2016-02-29 06:14:12
Documents
3
Period of Report
2016-02-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d145563d8k.htm 8-K 14178
2 EX-99.1 d145563dex991.htm EX-99.1 12445
3 GRAPHIC g145563g17b34.jpg GRAPHIC 9695
  Complete submission text file 0001193125-16-483467.txt   41547
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36457 | Film No.: 161464758
SIC: 2834 Pharmaceutical Preparations